http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0292475-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0a501fcf228975a489f9dd0193d4028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_680e85270dd3643f5f99652616e579cb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C2202-16
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02C9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02C7-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02C7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02B3-00
filingDate 1986-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_109a17b72c6e6b823f3761990803b5d4
publicationDate 1988-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0292475-A1
titleOfInvention POLARIZING LENS, OPPERABLE FOR ULTRAVIOLET RADIATION AND BLUE LIGHT.
abstract A lens (12) substantially stops horizontally polarized light and selectively stops wavelengths between 300 and 549 nanometers. This selective stopping is controlled by a point transmission filter (14) chosen so as to transmit at 450, 500, 515, 530, or 550 nanometers. The specific stop and transmission point chosen depends on the ultimate use / environment of the lens (12). If a filter is chosen which transmits at 450, it stops the wavelengths between 300 and 449 nanometers before a transmission takes place at 450 nanometers; similarly, a filter transmitting at 550 stops the wavelengths between 300 and 549 nanometers before a transmission takes place at 550 nanometers. The lens (12) also allows the transmission of 30 to 40% of the wavelengths above 625 nanometers. The filter (14) combined with a polarizer (16) stops harmful ultraviolet radiation and blue light. While wearing lenses that stop only blue light provides a beneficial and soothing effect, the addition of a polarizer (16) significantly enhances this soothing effect while improving vision without visual discomfort.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019025465-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7531236-B2
priorityDate 1986-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2236479-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25201348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414864229
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507128

Total number of triples: 30.